Results 71 to 80 of about 25,773 (228)
ABSTRACT Introduction Viral hepatitis remains a major global public health challenge, with heterogeneous epidemiological patterns across geographic and socioeconomic contexts. In the Brazilian Amazon, evidence remains limited, particularly regarding long‐term trends.
Jamilla Karla Corrêa Reis +6 more
wiley +1 more source
Increase risk of HBeAg-negative chronic hepatitis B with older age at HBeAg seroconversion
Background: Recent evidence suggests that delayed HBeAg seroconversion is associated with poorer outcome. We aim to determine the incidence of HBeAg-negative chronic hepatitis B (CHB) according to the age at which HBeAg seroconversion occurs. Methods:
Fung, JYY +9 more
core +1 more source
A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice. [PDF]
Despite the availability of an effective vaccine, hepatitis B virus (HBV) infection remains a major health problem. HBV e antigen (HBeAg)-negative strains have become prevalent.
Lei Wang +7 more
doaj +1 more source
HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients [PDF]
This study aimed to evaluate the predictive values of hepatitis B e antigen (HBeAg) and hepatitis B surface antigen (HBsAg) levels in 171 Chinese patients with chronic hepatitis B who received a 48-week course of pegylated interferon alfa-2b therapy at 1.5 mcg/kg.HBsAg, HBeAg, and hepatitis B virus (HBV) DNA levels were measured at baseline and weeks ...
Yang, Song +29 more
openaire +2 more sources
Chronic Hepatitis B in the United States: Current Landscape, Unmet Needs and Future Directions
ABSTRACT Chronic hepatitis B (CHB) infection represents a major public health challenge in the US, with substantial unmet needs related to timely diagnosis, treatment, monitoring and disease management. This narrative review explores the CHB landscape in the US, including gaps in patient care, the evolving therapeutic landscape, the clinical utility of
Chari Cohen +3 more
wiley +1 more source
Continuous variables: median (25th, 75th percentiles); categorical variables: numbers(percentages)IFN: interferon; ALT: alanine aminotransferase; ULN: upper limit of normal; HBeAg: hepatitis B e antigen; HBsAg: hepatitis B surface antigenFactors ...
Jee-Fu Huang (292609) +10 more
core +1 more source
The identification of predictive indices for hepatitis B e antigen seroconversion (HBeAg SC) in patients with chronic hepatitis B (CHB) remains a challenge.
Tong Zhao +7 more
doaj +1 more source
Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-)
The seroprevalence of hepatitis B virus (HBV) and its impact on pregnancy outcomes of women from Shaanxi Province (China) was assessed. Risk factors for mother-to-child transmission (MTCT) were evaluated based on HBV-related seroprevalence data.Viral markers and biochemical parameters were assessed in HBsAg-positive mothers and their infants out of 13 ...
Chen, Tianyan +13 more
openaire +2 more sources
Background: Hepatitis B virus (HBV) is a potentially life-threatening liver infection which may progress to liver failure and cirrhosis. Intrahepatic expression patterns of viral antigens detected by immunohistochemistry may have prognostic implications ...
Aysegul Sari +5 more
doaj +1 more source
Cumulative rates of a complete virological response (CVR) at week 96 according to HBeAg status.
Comparison of CVR between HBeAg (+) patients and HBeAg (-) patients (80.0% vs. 93.2%, P < 0.001). HBeAg, hepatitis B e antigen.
Si Hyun Bae (479006) +5 more
core +1 more source

